Optinsight Hidden Consent
Hidden opt-ins and opt-outs sitting in your CRM nowBlogCRMHCPData quality

Hidden opt-ins and opt-outs sitting in your CRM now

Michel van KoningsbruggeMichel van KoningsbruggeOctober 9, 2026
GDPR for Pharma
GDPR for pharma: A practical framework for HCP dataHCPEU GDPRBlog

GDPR for pharma: A practical framework for HCP data

Martijn van den CorputMartijn van den CorputOctober 6, 2026
Mapping HCP journey
Mapping the HCP journey: Where permission fits bestBlogHCPConsent collection

Mapping the HCP journey: Where permission fits best

Martijn van den CorputMartijn van den CorputOctober 5, 2026
GDPR for Biotech
GDPR for biotech: Engaging HCPs with consent in EuropeEU GDPRBlog

GDPR for biotech: Engaging HCPs with consent in Europe

Martijn van den CorputMartijn van den CorputOctober 2, 2026
optinsight consent management solution software contact
Product update what’s new in the OptInsight Consent & Preference platformBlog

Product update what’s new in the OptInsight Consent & Preference platform

Martijn van den CorputMartijn van den CorputSeptember 29, 2026
Omnichannel engagement
Brand impact of not processing HCP data according to consentBlog

Brand impact of not processing HCP data according to consent

Martijn van den CorputMartijn van den CorputMay 19, 2026
CRM CPM OptInsight
Beyond CRM: Pharma is entering a consent crisisCRMNews

Beyond CRM: Pharma is entering a consent crisis

Martijn van den CorputMartijn van den CorputMarch 9, 2026
Explanation video the data challenge in pharma
Video: The data challenge in pharmaNews

Video: The data challenge in pharma

Martijn van den CorputMartijn van den CorputFebruary 9, 2026
Omnichannel engagement
Omnichannel engagement: Will you scale risk or impact?Blog

Omnichannel engagement: Will you scale risk or impact?

Martijn van den CorputMartijn van den CorputJanuary 14, 2026
OptInsights 44: The overlooked link between communication preferences and HCP consentBlog

OptInsights 44: The overlooked link between communication preferences and HCP consent

Martijn van den CorputMartijn van den CorputSeptember 26, 2025
Pharma and biotechs are burning money as a result of poor data quality
OptInsights 43: Pharma and biotechs are burning money as a result of poor data quality.Blog

OptInsights 43: Pharma and biotechs are burning money as a result of poor data quality.

Martijn van den CorputMartijn van den CorputSeptember 4, 2025
HCP Engage
HCP Engage: consent as a serviceNews

HCP Engage: consent as a service

Martijn van den CorputMartijn van den CorputAugust 21, 2025
New E-book: Eliminate Your Conversion Killers and Boost Conversions by Up to 30%News

New E-book: Eliminate Your Conversion Killers and Boost Conversions by Up to 30%

Martijn van den CorputMartijn van den CorputJuly 15, 2025
Partnership PrivIntelligent and OptInsightNews

Partnership PrivIntelligent and OptInsight

Martijn van den CorputMartijn van den CorputJune 23, 2025